Veeva Systems Inc. (VEEV)

Market Cap	50.25B +6.7%
Revenue (ttm)	3.46B +16.5%
Net Income	1.01B +25.3%
EPS	6.10 +25.5%
Shares Out	161.91M
PE Ratio	50.88
Forward PE	32.15
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,730,462
Open	319.95
Previous Close	313.03
Day's Range	306.58 - 319.95
52-Week Range	148.05 - 319.95
Beta	0.93
Analysts	Buy
Price Target	297.04 (-4.29%)
Est. Earnings	Nov 19, 2026

About VEEV

Veeva Systems Inc. provides cloud-based software for the life sciences industry in North America, Europe, the Asia Pacific, the Middle East, Africa, and Latin America. The company offers Veeva Commercial Cloud comprising Veeva Vault CRM Suite for pharmaceutical and biotechnology companies; Veeva Medical that provides source of medical content across multiple channels and geographies; Veeva PromoMats, an end-to-end content and digital asset management solution; and Veeva Crossix, an analytics platform for pharmaceutical brands. It also provides ...

• Industry: Health Information Services
• Sector: Healthcare
• IPO Date: Oct 16, 2013
• Employees: 7,928
• Stock Exchange: NYSE
• Ticker Symbol: VEEV
• Website: https://www.veeva.com

Financial Performance

In fiscal year 2026, Veeva Systems's revenue was $3.20 billion, an increase of 16.34% compared to the previous year's $2.75 billion. Earnings were $908.91 million, an increase of 27.27%.

Analyst Summary

According to 29 analysts, the average rating for VEEV stock is "Buy." The 12-month stock price target is $297.04, which is a decrease of -4.29% from the latest price.

Price Target

$297.04

(-4.29% downside)

Analyst Consensus: Buy

Data Sources: S&P Global Market Intelligence, CBOE, and more

Fundamental and historical data is provided by S&P Global Market Intelligence. Real-time stock price data is provided by CBOE and 15-minute delayed consolidated tape pricing data is provided by Nasdaq UTP.

Last checked:

Oct 17, 2026

Data Sources Report a data error